[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 22, Number 2 (1-2017) ::
3 2017, 22(2): 141-146 Back to browse issues page
Adiponectin versus Bevacizumab in Decreasing Corneal Neovascularization
AR Baradaran-Rafii, A Ashnagar , S Heidari-Keshel, A Baradaran-Rafii, S Jabbedari, AR Lashay, A Alishiri
Abstract:   (105 Views)
Purpose: To compare the effect of adiponectin versus bevacizumab on reducing corneal neovascularization
Methods: This study was performed on 40 eyes of 20 New Zealand Albino male rabbits. Corneal neovascularization was induced by a 7-0 silk suture 2mm long and 1 mm away from the limbus. Rabbits were randomly divided into two groups of ten. In the first group, adiponectin eye drop and artificial tears were administered in the right and left eyes, respectively. In the second group, adiponectin eye drop was applied in the right eye and bevacizumab eye drop was used in the left eye for 14 days. The rabbits were examined regularly. Imaging was performed at each visit.  The area of corneal vascularization and the length of vessels were measured and compared.
Results: At the end of 14 days, the average length of vessels in the rabbits treated with adiponectin decreased from 2.12 ± 0.32 mm to 0.89 ± 0.46 mm, (57.68 ± 19.98% decrease ;1.24 ± 0.51mm) (P<0.001).  The length of vessels were decreased by 57.68% ± 19.98% and 42.49% ± 27.17% in the adiponectin and bevacizumab groups, respectively (P= 0.527). At the end of 14 days, the average surface area of vessels in the rabbits  treated with adiponectin reduced from 5.02±1.50 mm2 to 1.40 ±0.75 mm2 (%70.64± 17.76 decrease; 3.63±1.57 mm2) (P<0.001) . The mean surface area of vascularization was decreased by 70.64% ±17.76% and 48.24% ±19.23% in the adiponectin versus bevacizumab group, respectively (P= 0.013).
Conclusion: The results of this study suggest that adiponectin can potentially decrease youn corneal neovascularization. Its effect seems to be at least comparable to bevacizumab.
 
 
Keywords: Adiponectin, Bevacizumab, Corneal Neovascularization
Full-Text [PDF 211 kb]   (29 Downloads)    
Type of Study: Research | Subject: Ophthalmology
Send email to the article author

Add your comments about this article
Your username or email:

Write the security code in the box >



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Baradaran-Rafii A, Ashnagar A, Heidari-Keshel S, Baradaran-Rafii A, Jabbedari S, Lashay A et al . Adiponectin versus Bevacizumab in Decreasing Corneal Neovascularization. 3. 2017; 22 (2) :141-146
URL: http://binajournal.org/article-1-866-en.html
Volume 22, Number 2 (1-2017) Back to browse issues page
مجله چشم‌پزشکی بینا Bina Journal of Ophthalmology
Persian site map - English site map - Created in 0.051 seconds with 807 queries by yektaweb 3503